AnaptysBio, Inc.

Historical 13F Holders

Symbol
ANAB
CUSIP
032724106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 032724106 since 12/18/2024, largest first.

Filer % of Class Filed
EcoR1 Capital, LLC 13D/A
27.8% 11/18/2026
Event 11/16/2026
BlackRock, Inc. 13G/A 6.2% 4/17/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (10)
Goldman Sachs Group Inc 13G/A
4.5% 11/12/2025
Event 9/30/2025
Morgan Stanley 13G/A
3.6% 2/11/2026
Event 12/31/2025
First Light Asset Management, LLC 13G/A
3.1% 11/14/2025
Event 9/30/2025
Sirenia Capital Management LP 13G/A
3.1% 11/16/2026
Event 9/30/2026
Millennium Management LLC 13G/A
2.9% 1/16/2026
Event 12/31/2025
Frazier Life Sciences Public Fund, L.P. 13G/A
1.5% 2/14/2025
Event 1/31/2025
FMR LLC 13G/A
0.9% 6/6/2025
Event 5/30/2025
Point72 Asset Management, L.P. 13G/A
0.2% 5/15/2026
Event 3/31/2026
Fairmount Funds Management LLC 13G/A
0% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 229 30.8 M $1.55B
2026 Q2 216 30.1 M $2.05B
2026 Q1 209 28.3 M $1.55B
2025 Q4 181 29.4 M $1.42B
2025 Q3 166 31.7 M $980M
2025 Q2 149 36.8 M $816M
2025 Q1 155 40.0 M $743M
2024 Q4 142 35.4 M $469M
2024 Q3 166 33.6 M $1.13B
2024 Q2 136 29.8 M $747M
2024 Q1 134 29.2 M $658M
2023 Q4 120 30.2 M $646M
2023 Q3 117 30.3 M $545M
2023 Q2 117 30.2 M $615M
2023 Q1 115 31.0 M $675M
2022 Q4 120 33.0 M $1.02B
2022 Q3 115 32.6 M $831M
2022 Q2 126 31.2 M $633M
2022 Q1 133 29.7 M $736M
2021 Q4 140 27.8 M $964M
2021 Q3 129 27.6 M $749M
2021 Q2 125 27.8 M $721M
2021 Q1 125 29.2 M $629M
2020 Q4 138 27.9 M $601M
2020 Q3 134 29.1 M $429M
2020 Q2 125 30.0 M $670M
2020 Q1 118 31.2 M $441M
2019 Q4 124 28.3 M $460M
2019 Q3 122 29.0 M $1.02B
2019 Q2 129 30.2 M $1.70B
2019 Q1 131 29.1 M $2.13B
2018 Q4 122 29.0 M $1.85B
2018 Q3 136 28.6 M $2.85B
2018 Q2 124 25.0 M $1.78B
2018 Q1 134 24.3 M $2.53B
2017 Q4 116 23.8 M $2.39B
2017 Q3 71 17.7 M $620M
2017 Q2 52 13.7 M $328M
2017 Q1 51 13.8 M $382M